ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ:BSMD) (“BioSphere”) – a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – announced today that Martin Joyce, executive vice president and chief financial officer, is scheduled to present at The Wall Street Analyst Forum 19th Annual Analyst Conference on Tuesday, September 9, 2008 at 10:30 a.m. Eastern time. The conference will be held at The University Club in New York City from September 8-10, 2008.
